MYO1E anticorps

N° du produit ABIN7116614

L’anticorps Lapin Polyclonal anti-MYO1E a été validé pour WB et ELISA. Il convient pour détecter MYO1E dans des échantillons de Humain, Souris et Rat.

Aperçu rapide pour MYO1E anticorps (ABIN7116614)

Antigène: MYO1E (Myosin IE (MYO1E))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MYO1E est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-MYO1E anticorps

Fonction: MYO1E antibody

Purification: Immunogen affinity purified

Pureté: ≥95 % as determined by SDS-PAGE

Immunogène: myosin IE

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: -20°C for 12 months

Date de péremption: 12 months

Détails sur MYO1E

Antigène: MYO1E (Myosin IE (MYO1E))

Autre désignation: MYO1E

Sujet:

Synonyms: Unconventional myosin-Ie|Myosin-Ic|Unconventional myosin 1E|MYO1E|MYO1C

Background: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. In dendritic cells, may control the movement of class II-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via ARL14EP and ARL14.

Poids moléculaire: 127 kDa

ID gène: 4643

UniProt: Q12965

Pathways: Platelet-derived growth Factor Receptor Signaling